Filter
1546
Filtered Results: 1546
Text search:
pharmaceutical
policies
Featured
Recommendations
137
New Publications
437
Language
Document type
No document type
809
Studies & Reports
326
Guidelines
205
Strategic & Response Plan
86
Manuals
66
Training Material
16
Situation Updates
13
Fact sheets
13
Resource Platforms
6
Brochures
3
Infographics
3
Countries / Regions
Global
68
Kenya
66
Ethiopia
59
India
51
South Africa
39
Nigeria
37
Western and Central Europe
36
Uganda
34
Namibia
31
Sierra Leone
28
Nepal
25
Liberia
25
Ghana
24
Malawi
24
Tanzania
23
Bangladesh
23
Zambia
22
Africa
21
Ukraine
20
Rwanda
19
Latin America and the Carribbean
17
Cambodia
16
Lesotho
15
South–East Asia Region
15
Eastern Europe
15
Indonesia
14
Syria
13
Zimbabwe
13
Philippines
13
Myanmar / Burma
11
West and Central Africa
10
East and Southern Africa
9
Botswana
9
Congo, Democratic Republic of
7
Eastern Europe and Central Asia
7
Eswatini/ Swaziland
7
Cameroon
6
Senegal
6
Haiti
6
Asia
6
Middle East and North Africa
6
Thailand
5
Germany
5
Pakistan
5
Albania
4
Burkina Faso
4
Mozambique
4
Venezuela
4
Western Pacific Region
4
Vietnam
4
South Sudan
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea
3
USA
3
Brazil
3
El Salvador
2
China
2
Fiji
2
Lithuania
2
Jordan
2
North America
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Chile
1
Iran
1
Kyrgyzstan
1
Niger
1
Mongolia
1
Bulgaria
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Argentina
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Honduras
1
Angola
1
Chad
1
Iraq
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
671
Public Health
86
Clinical Guidelines
82
Key Resources
77
Women & Child Health
39
Pharmacy & Technologies
21
Capacity Building
8
Toolboxes
AMR
167
COVID-19
115
Pharmacy
106
TB
83
Mental Health
80
HIV
72
Rapid Response
46
Planetary Health
45
NCDs
38
NTDs
33
Global Health Education
33
Health Financing Toolbox
31
Caregiver
27
Conflict
25
Malaria
17
Ebola & Marburg
13
Refugee
10
Disability
8
Specific Hazards
7
Natural Hazards
7
Polio
6
Zika
3
Cholera
2
Social Ethics
2
Mental health issues are usually given very low priority in health service policies. Although this is changing, African countries are still confronted with so many problems caused by communicable diseases and malnutrition that they have not woken up to the impact of mental disorders. Every country m...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
This guideline aims to improve the quality of donations and the management thereof and serve as the basis for policies of the State and other organizations in the giving and receiving of donations of medicines, medical devices and IVDs.
Over the last three or four decades, there has been an enorm...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,...
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
